Antiviral treatment or mAbs for persistent SARS-COV-2 infection in patients with hematologic malignancies: A case series

J Med Virol. 2023 Jun;95(6):e28865. doi: 10.1002/jmv.28865.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19*
  • Hematologic Neoplasms* / complications
  • Humans
  • Research
  • SARS-CoV-2